Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Tape measurement vs clinical palpation Neonatal detection of large‐for‐gestational age · Pregnant women with singleton fetuses who were of 20 weeks' gestation and above. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth (2015) · Cochrane | no estimate extracted | NR | No studies |
Tape measurement vs clinical palpation Intrauterine death · Pregnant women with singleton fetuses who were of 20 weeks' gestation and above. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth (2015) · Cochrane | no estimate extracted | NR | No studies |
Tape measurement vs clinical palpation Neurodevelopmental outcome in childhood · Pregnant women with singleton fetuses who were of 20 weeks' gestation and above. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth (2015) · Cochrane | no estimate extracted | NR | No studies |
Intermittent LTRA vs placebo Serious adverse events · episodic viral wheeze in children Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children (2015) · Cochrane | no estimate extracted | NR | No studies |
Maintenance LTRA vs placebo Serious adverse events · episodic viral wheeze in children Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death · adults with fibromyalgia Milnacipran for pain in fibromyalgia in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Hospitalisations · individuals with stable bronchiectasis Airway clearance techniques for bronchiectasis (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events (AEs) · individuals with stable bronchiectasis Airway clearance techniques for bronchiectasis (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs disopyramide Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs tocainide Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs tocainide Ventricular fibrillation · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs mexiletine Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs propafenone All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs propafenone Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs propafenone Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs placebo or no intervention Overall survival at 30 days after myocardial infarction · patients with acute myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs amiodarone All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs amiodarone Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs amiodarone Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs dimethylammonium Ventricular fibrillation · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs aprindine Ventricular fibrillation · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol All‐cause mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol Cardiac mortality · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol Overall survival at 30 days after myocardial infarction · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Lidocaine vs pirmenol Ventricular fibrillation · patients with myocardial infarction Prophylactic lidocaine for myocardial infarction (2015) · Cochrane | no estimate extracted | NR | No studies |
Recombinant human soluble thrombomodulin vs heparin Resolution of respiratory failure · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Recombinant human soluble thrombomodulin vs heparin Renal failure · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Recombinant human soluble thrombomodulin vs heparin Shock · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Dermatan vs heparin Resolution of respiratory failure ‐ not measured · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Dermatan vs heparin Renal failure · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Dermatan vs heparin Shock · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Human activated protein C vs heparin Resolution of respiratory failure · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Human activated protein C vs heparin Renal failure · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Human activated protein C vs heparin Shock · DIC Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Morita therapy plus pharmacological therapy vs pharmacological therapy alone Quality of life measures ‐ endpoint data or change data · people with anxiety disorders Morita therapy for anxiety disorders in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Morita therapy plus pharmacological therapy vs pharmacological therapy alone Measures of functioning ‐ endpoint data or change data · people with anxiety disorders Morita therapy for anxiety disorders in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Morita therapy vs pharmacological therapy Acceptability ‐ drop‐outs for any reason · people with social phobia Morita therapy for anxiety disorders in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Morita therapy vs pharmacological therapy Measures of obsession and compulsion endpoint data or change data · people with social phobia Morita therapy for anxiety disorders in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Morita therapy vs pharmacological therapy Quality of life measures endpoint data or change data · people with social phobia Morita therapy for anxiety disorders in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Morita therapy vs pharmacological therapy Measures of functioning endpoint data or change data · people with social phobia Morita therapy for anxiety disorders in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Morita therapy plus pharmacological therapy vs pharmacological therapy alone Global state responders · people with anxiety disorders Morita therapy for anxiety disorders in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Mortality · critically ill patients Non‐pharmacological interventions for sleep promotion in the intensive care unit (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Economic outcomes · critically ill patients Non‐pharmacological interventions for sleep promotion in the intensive care unit (2015) · Cochrane | no estimate extracted | NR | No studies |
Vitrectomy vs observation Hole recurrence · participants with idiopathic macular hole Vitrectomy for idiopathic macular hole (2015) · Cochrane | no estimate extracted | NR | No studies |